NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

Here are a couple of scenarios for the board to consider by the sudden 250M share increase taking total share count to 1.2B
1) Increasing the share count by an additional 250 million could indicate that the company is expecting to be trading in the penny range for some time and are not looking to unblind the data this year after maybe seeing the results of the Spring scrub. In this scenario they would still need millions of millions of shares to keep the lights on until next year and are expecting to continue toxic financing between 16 and 24 cents. This scenario would obviously be based on possibly a positive interim blinded paper indicating that the company is still hopeful of trial success but need to improve their overall OS figures by one more year. This paper would then be used to bring in new investors over the coming year into 2019.

2) If we are looking at a great publication and a big reveal and unblinding of DCVAX-L phase 3 at this years ASCO indicating success we would expect the SP to rise north of $2 and maybe as high as $5. 250 million shares multiplied by this SP would allow the company to raise up to a Billion dollars. What we should be asking ourselves is why would the company need this type of money other than they would be planning to go it alone and build themselves into a BP without any backing except future shareholders. In this scenario I would fully expect NWBO to merge with Cognate and Advent and possible rename themselves as Advent say for example.

We would all prefer option 2 at this point but I really question the amount of additional shares they are asking us to vote on and we as investors should be allowed to ask for real concrete information regarding a path forward so we can feel comfortable to dilute to the extent they are asking us to do.

Just my 2 cents.